– First Runner-up HD Medical Only Healthcare Company Chosen from over 1000 Global Startup Entries –

SVOD Award

Santa Clara, CA – May 29, 2019, HD Medical, Inc. of Santa Clara, CA today announces it has been awarded First Runner-up in the Silicon Valley Open Doors Technology Investment Pitch Competition. The company reviewed the impact of how its innovative new ECG-enabled intelligent stethoscope, HD Steth™, is saving lives through HD Medical’s Screening as a Service (SaaS) business model.

“We awarded HD Medical SVOD19’s First Runner-up Award from 26 start-up finalists selected from more than 1000 applications,” said Anna Dvornikova, Managing Partner of TEC Ventures, the founder of SVOD. “Some of the best Silicon Valley investors judged companies during the 2-day conference. To win this award, HD Medical demonstrated truly disruptive ideas and impact, perfect product-market fit, a passionate team and the utmost readiness to raise funds.” continues Dvornikova.

HD Medical’s Social Impact
“HD Medical addresses both UN Sustainable Development Goals and UNICEF Custodian Indicators with a mass screening program in India where we are training 50 healthcare workers on HD Steth to screen over 500,000 children during 2019,” said Arvind Thiagarajan, Founder and CEO of HD Medical. “This is the largest initiative of its kind by threefold. Over the next 5 years, we will train over 3,000 healthcare workers who will screen 50 million underserved children worldwide.” adds Thiagarajan.

HD Steth™ Leveraging AI to Accelerate Risk Assessment
HD Steth delivers high-fidelity audio quality plus real-time visualization of heart sounds and ECG waveforms on a mobile device. In addition, HD Steth leverages AI-driven murmur detection with clinically proven accuracy of 90% sensitivity and 99% specificity. HD Steth can accurately and quickly identify congenital heart disease (CHD) at point-of-care accelerating risk assessment for the underserved.

About SVOD
Silicon Valley Open Doors is an international startup investment conference focused on Impact Through High-Tech Entrepreneurship; early startup founders from all over the world meet successful founders, famous Silicon Valley investors, and industry legends, who are shaping our lives today and influencing our future.

In SVOD’s 15-year history, every 3rd participating startup has been funded and about $850M has been raised to date from funds such as Draper Associates, Founders Fund, Salesforce, Yuri Milner, Y Combinator etc. For more information, visit www.svod.org.

About HD Medical, Inc.
HD Medical, Inc. is a Silicon Valley-based innovator of digital health solutions for AI-enabled detection and management of cardiovascular disease (CVD). The company delivers its intelligent cardiac care solutions and products globally to medical professionals, hospitals and medical institutions as well as veterinarians through channel partners. For more information please visit www.hdmedicalgroup.com.

HD Medical, Inc. is a Silicon Valley-based innovator of digital health solutions for AI-enabled detection and management of cardiovascular disease (CVD). The company delivers its intelligent cardiac care solutions and products globally to medical professionals, hospitals and medical institutions as well as veterinarians through channel partners. For more information please visit www.hdmedicalgroup.com.

Note to editors: HD Steth is a trademark of HD Medical, Inc. All other company, organization, product or alliance names herein remain the property of their respective owners.

– With Dual Board Certification in Internal Medicine and Preventive Medicine, Dr. Ku Brings Valuable Insights –

Santa Clara, CA – April 23, 2019, HD Medical, Inc. of Silicon Valley, CA today announces the expansion of its senior management team with Dr. Rosemary Ku, MD/MBA/MPH joining as Chief Medical Officer. In this role, Dr. Ku will guide HD Medical’s product vision and road map, interface with the FDA, oversee numerous clinical trials as well as contribute to marketing and investor relations.

Dr. Rosemary is a practicing physician at Kaiser Permanente and comes to HD Medical from Lark Health where she served as the Chief Medical Officer focusing on chronic disease management. She previously served as Chief Medical and Strategy Officer for Restore Health and helped build the company from concept through acquisition by Zillion in 2017.

“For-profit companies have typically focused on building new technologies for consumers with both access and willingness to pay. HD Medical is different. HD Medical strives to develop the world’s best cardiac screening and monitoring tools for communities that need it the most,” said Dr. Ku, Chief Medical Officer at HD Medical, Inc. “With this mission, the company is rapidly opening new markets at the intersection of social impact and growth in India and rest of Asia through mass screening of children for congenital heart disease. HD Medical is pioneering a model for how companies in Silicon Valley can accelerate the dissemination of life-changing technology to underserved communities while still meeting investor expectations. I’m honored to help drive HD Medical’s clinical validation strategy, social impact, and growth.” adds Dr. Ku.

“HD Medical’s ability to gather comprehensive cardiovascular data remotely is a game changer in modern healthcare. The potential to intervene before catastrophic events can save lives and maximize the quality of life for those at risk. Dr. Ku will not only help clinically validate HD Medical’s existing technology but will also leverage cutting edge science to develop proprietary tools for the advancement of cardiac care. “said Arvind Thiagarajan, Founder and CEO of HD Medical, Inc.

About HD Medical, Inc.

HD Medical, Inc. is a Silicon Valley-based innovator of digital health solutions for AI-enabled detection and management of cardio vascular disease (CVD). The company delivers its intelligent cardiac care solutions and products globally to medical professionals, hospitals and medical institutions as well as veterinarians through channel partners. For more information please visit www.hdmedicalgroup.com.

Note to editors: HD StethVet is a registered trademark of HD Medical, Inc. All other company, organization, product or alliance names mentioned herein remain the property of their respective owners.

Click here to view PDF.

Santa Clara, CA – February 14, 2019, ELEVET Technologies of Worthington, OH and HD Medical, Inc. of Silicon Valley, CA today announce they have signed a distribution agreement. According to the terms of the agreement, ELEVET will offer HD StethVet® to the veterinarian community nationwide. HD Steth is an intelligent stethoscope with integrated EKG; this provides instantaneous insights from evidence-based medical diagnosis of an animal’s health.

HD StethVet’s ruggedized packaging has the look and feel of the familiar stethoscope making it a natural transition for veterinarians. HD StethVet transforms the way medicine is practiced at the point-of-care through real-time visualization of cardiac waveforms, EKG and body sounds on a mobile device. With patented sound processing technology which provides optimum amplification and noise cancellation, HD StethVet is perfect for environments with significant ambient sound such as a busy veterinary clinic.

“We are very excited to have ELEVET Technologies offering HD Medical’s latest intelligent stethoscope solution, HD StethVet, to help veterinarians more effectively care for their animal patients,” states Arvind Thiagarajan, HD Medical Founder and CEO. “Additionally, the ability to display, record, save and transfer visual plus audio health data for group consumption makes HD StethVet ideal for veterinary colleges where the next generation of veterinarians are being taught.

“Now veterinarians have access to the only advanced intelligent stethoscope with EKG, enabling accurate and instant diagnosis of animal cardiac and body conditions,” said Chris Scott, ELEVET Technologies President. “This is particularly important in clinics where follow-up tests can be difficult, time consuming and costly.” HD StethVet is consistent with ELEVET’s philosophy of delivering the latest design, technological and usability breakthroughs to better serve veterinarians and their patients, helping to grow veterinary practices.


About ELEVET

ELEVET Technologies is a marketing and distribution company of high-quality medical equipment and supplies to help grow veterinary practices. We have over 20-years of industry experience, supplying products from leading manufacturers around the world. For more information please visit www.ele-vet.com.

About HD Medical, Inc.

HD Medical, Inc. is a Silicon Valley-based innovator of digital health solutions for AI-enabled detection and management of cardio vascular disease (CVD). The company delivers its intelligent cardiac care solutions and products globally to medical professionals, hospitals and medical institutions as well as veterinarians through channel partners. For more information please visit www.hdmedicalgroup.com.

Note to editors: HD StethVet is a registered trademark of HD Medical, Inc. All other company, organization, product or alliance names mentioned herein remain the property of their respective owners.

Click here to view PDF.

It’s February 7thand the medical community is observing Congenital Heart Defect Awareness Week sponsored by the American Heart Association to encourage awareness and education about congenital heart defects (CHDs). This week has been set aside to honor those born with a heart defect and all of the families and friends touched by children with heart defects. As participants of multiple CHD trials and validation studies lets discuss CHD challenges and solutions for rapid CHD detection.

According to the American Heart Association, about one child out of 100 births every year in the US is born with a CHD condition. This is due to a problem that happens as the child’s heart is developing during pregnancy, before the child is born. CHDs are the most common type of birth defects and people live with heart defects throughout their lives. As we all know, there are many types of congenital heart defects and the most common involve the inside walls of the heart, the valves of the heart, or the large blood arteries and veins carrying blood to and from the heart. Some of these heart defects require no treatment; however others require treatment soon after birth. Treatments which have many dependencies can include medications, catheter procedures, surgery, and sometimes heart transplants. Because cardiac diagnosis and treatment has greatly improved, more children are surviving and many CHD adults are living full complete lives. 

Regardless of treatment, detection and monitoring are key for managing CHD; the gold standard has been ultrasound echocardiogram, however recent clinical studies in India have validated that new EKG-enabled intelligent stethoscope technology can serve as a precursor to ultrasound echocardiogram for CHD detection and monitoring.

This new technology solution which integrates digital auscultation with EKG functionality and diagnostic imaging in the familiar shape and size of a stethoscope is called HD Steth.  HD Steth leverages digital health technologies to instantly detect and diagnose CHD. This represents a paradigm shift at the point-of-care setting.  Now medical professionals can instantly identify a patient’s cardiac condition, capture and share patient data, and identify cardiac defects in real-time improving patient quality-of-life.

– Screening Study Utilizes HD Medical’s New ECG-enabled Intelligent Stethoscope, HD Steth™ –

Mumbai, India – November 28, 2018, HD Medical, Inc. of Silicon Valley announces its participation in the large-scale Divine Mother & Child Health Program (DMCHP) cardiac screening study of 100,000 children at Sri Sathya Sai Sanjeevani Centre for Child Heart Care & Training in Pediatric Cardiac Skills, Public Health Outreach Program, in Kharghar, Navi Mumbai, India commencing on November 27, 2018.

Importance of the Cardiac Screening Study
The health of a child is the true wealth of the Nation. In India, over 300,000 children are born with congenital heart diseases (CHD), and thousands of them die every year without even the basic medical care1. Recognizing this problem and the need to screen and save the lives of infants, children and young adults, the Sri Sathya Sai Sanjeevani Centre for Child Heart Care & Training in Pediatric Cardiac Skills, coming up at Kharghar, Navi Mumbai, launched the Divine Mother & Child Health Program to screen 100,000 children from rural areas for CHD. The Program shall commence in Navi Mumbai and Panvel Taluk of Raigad District. Sri Sathya Sai Sanjeevani is a dedicated center offering cardiac care for the children of the State and the Nation Totally Free of Cost.

“Sri Sathya Sai Sanjeevani embarks on its CHD Free Maharashtra Mission, by creating an entire ecosystem conducive for ‘prevention to cure’ with the core value of compassion,” said Mr. C Sreenivas, Chairman of Sri Sathya Sai Sanjeevani Hospitals. “The program aims to take health services to the doorstep of the most needy individuals in the community, especially rural children, and provide quality screening, detection and management services strengthened significantly by active stakeholder participation with nationally recommended guidelines and protocols.”

HD Medical’s HD Steth Employed in Study
Collaborating with a world leading innovator and technology partner, HD Medical Inc. from the USA, Sri Sathya Sai Sanjeevani’ s DMCHP has deployed diagnostic devices with cutting edge technology to enable CHD screening of the children at a rapid rate. “HD Medical has developed the world’s first Intelligent Stethoscope with Integrated ECG called HD Steth which can provide Instant Cardiac Insight,” said Mr. Arvind Thiagarajan, Founder & CEO of HD Medical, Inc. “HD Steth enables AI-based real-time visualization of cardiac waveforms and defects on a Bluetooth smart device App that enables cloud connectivity and AI-based interpretations for further analysis and diagnosis, all within a few minutes.” adds Mr. Thiagarajan. This innovative technology drastically reduces critical time lag in diagnosis and fosters evidence-based detection at point of care and Real time collaboration with specialists.

HD Steth

HD Medical’s HD Steth Intelligent Stethoscope with Integrated ECG

HD Steth App

HD Steth app displays heart and ECG waveforms on a smart mobile device

Realizing a Seamless Preventive Health Ecosystem As an important capacity building initiative, a state-of-the-art Pediatric Cardiac Screening & Training Skills Development Centre shall be set up at the hospital in Navi Mumbai to train medical and paramedical Government staff.

To align with the vision of Government of Maharashtra towards creating seamless preventive health ecosystem, the DMCHP shall actively collaborate with various Government departments such as the Department of Public Health, Department of Medical Education and Department of Women & Child Health Development.

The DMCHP shall also integrate a comprehensive screening of pregnant women aimed at antenatal and postnatal care. The program shall also cover infant and child health.
To further the nation’s commitment towards a healthy life for its mothers and children, the Divine Mother & Child Health Program emphasizes the need for individuals and institutions to take upon themselves this agenda and focus on the preventive aspect of healthcare spectrum.

About Sri Sathya Sai Sanjeevani Hospitals
Since their inception, Sri Sathya Sai Sanjeevani Hospitals have embarked on an inspiring journey of giving and receiving Selfless Love through serving over 75,000 children with Congenital Heart Disease to date. Sri Sathya Sai Health and Education Trust established in May 1970, is a Public Charitable Trust, under Section 12 A of the Income Tax Act, 1961 which runs these Health Care Institutions wherein services to all, irrespective of colour, class, religion, nation or financial status, are provided Totally Free of Cost. The Institutions are recognized by both the Central and State Governments as National Institutions of Public Service. To learn more please visit https://srisathyasaisanjeevani.org/

About HD Medical, Inc.
HD Medical, Inc. is a cardiac solutions innovator headquartered in Silicon Valley, California, USA. HD Medical designs and develops advanced medical products for use in screening and early detection of cardiac conditions. Coming from a tradition of helping to promote personal and community health, through exceptional healthcare diagnostic products and solutions, HD Medical, Inc. is committed to delivering “Higher Dimensions in Digital Health™”. The company delivers its innovative cardiac solutions and products to the Indian market through its distributors mentioned below:

Online distributor: Collateral Medical (http://www.colmed.in/hdsteth.html)
Contact no: 8108344766
Trade distributor: Mohaksh Systems
Contact no: +91 9833906161 & +91 9820139712
1. Lancet Journal

Press Release (PDF)

Care for and monitoring of cardiac diseases is a major challenge for the health community.  Currently thirty eight percent (38%) of deaths worldwide are attributable to cardiac disease and the associated cost of cardiac disease management is exceeding $1T per year.  Exasperating the situation, the ratio of population to specialists is in the range of 10,000 to 1 in the USA (higher elsewhere) creating challenges in making critical clinical decisions during the “golden hour” of a cardiac event.

Additionally, according to Dr. Nelson B. Schiller, MD, FACC, FRCP “Standardized auscultation tests given to medical students and fellows have found auscultation is either not taught well enough or students have difficulty learning it.  Results show that only 30% of medical students tested are able to detect typical heart sounds and murmurs versus the internal medicine residents getting up to 40% while Fellows reach into the 50 -60% range.”  In addition, according to Dr. Paul Rosen in his recent HealthcareSuccess.com blog “At the medical school at Stanford University, 35 percent of graduating students are forgoing residency training and taking jobs in start-ups instead. The cultures they see outside of health systems resonate more with their values.” Also, according to Rosen “in the area of patient safety, over 400,000 deaths in hospitals are due to medical errors each year, making medical errors the 3rd leading cause of death in the Unites States.”

These challenges are being overcome with recent advances in medical imaging along with increased computational power and the advent of mobility, wireless and other technologies.  This now allows patients to be treated and monitored more precisely and effectively and in ways that better meet their individual needs.

HD Medical’s HD Steth comes at a perfect inflection point as healthcare is shifting and focusing on wellness and prevention rather than treating patients after an incident.